HepaRegenix

Tubingen, Germany · Founded 2015 · Privately Held (backing)

Developer of novel therapies designed to treat acute and chronic liver diseases. HepaRegenix is based in Tubingen, Germany and was founded in 2015. Its last reported valuation was $43.2 million in Jan 2020. It has raised $45.3 million.

Last reported valuation
$43.2M
Oct 2026
Priced at
—
Total raised
$45.3M
Last round
—

Who backs HepaRegenix?

7 investors
InvestorType
High-Tech GründerfondsVenture capital
Novo HoldingsOther
Boehringer Ingelheim Venture FundOther
Wellington PartnersVenture capital
AscenionOther
Coparion—
Vesalius Biocapital Partners—
The directory is free. Investor activity — the working column — is Pro.Unlock prospecting columns

Membership and data by Private Market View

HepaRegenix investors

7 investors are on record for HepaRegenix, including High-Tech Gründerfonds, Novo Holdings, Boehringer Ingelheim Venture Fund and Wellington Partners.

Free account
More of HepaRegenix with a free account
  • ·Watch HepaRegenix: the Monday email on marks, rounds and moves
Create free account
No card required

Membership and data by Private Market View

For fundraisers
Work this list, don’t just read it

These 7 firms already write checks for companies like HepaRegenix. Build the wider list: every firm that has backed a company like this one, ranked by how often and how recently.

Find investors like these →

Membership and data by Private Market View